Cases 1 - 10 of 11
Actelion Pharmaceuticals US, Inc. et al v. MSN Laboratories Private Ltd. et al
as 1:2023cv00731
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd.
Defendant:
MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Nippon Shinyaku Co., Ltd v. Sarepta Therapeutics, Inc.
as 1:2023cv00553
Plaintiff:
Nippon Shinyaku Co., Ltd
Defendant:
Sarepta Therapeutics, Inc.
Petitioner:
Ryszard Kole
Actelion Pharmaceuticals US, Inc. et al v. Cipla Limited et al
as 1:2023cv00389
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd.
Defendant:
Cipla Limited and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals US, Inc. et al v. Alembic Pharmaceuticals Limited et al
as 1:2023cv00383
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd.
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals US, Inc. et al v. Lupin Ltd. et al
as 1:2023cv00150
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd. and Nippon Shinyaku Co., Ltd.
Defendant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Actelion Pharmaceuticals US, Inc. et al v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01450
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd.
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Nippon Shinyaku Co., Ltd. v. Sarepta Therapeutics, Inc.
as 21-2369
Plaintiff / Appellant:
NIPPON SHINYAKU CO., LTD.
Defendant / Appellee:
SAREPTA THERAPEUTICS, INC.
Nippon Shinyaku.,Ltd. v. Sarepta Therapeutics, Inc.
as 1:2021cv01015
Plaintiff:
Nippon Shinyaku.,Ltd. and Nippon Shinyaku Co.,Ltd.
Defendant:
Sarepta Therapeutics, Inc.
Cause Of Action: 35 U.S.C. § 1
ACTELION PHARMACEUTICALS LTD et al v. MSN PHARMACEUTICALS INC. et al
as 1:2020cv03859
Defendant:
ZYDUS WORLDWIDE DMCC, MSN LABORATORIES PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED and others
Plaintiff:
NIPPON SHINYAKU CO., LTD. and ACTELION PHARMACEUTICALS LTD
Cause Of Action: 15 U.S.C. § 1126
Nippon Shinyaku Co., Ltd. v. Iancu
as 19-1824
Plaintiff / Appellant:
NIPPON SHINYAKU CO., LTD.
Defendant / Appellee:
ANDREI IANCU, Director, U.S. Patent and Trademark Office
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
